Cognitive outcome in adults after bacterial meningitis

被引:138
作者
Hoogman, Martine [1 ]
van de Beek, Diederik [1 ]
Weisfelt, Martijn [1 ]
de Gans, Jan [1 ]
Schmand, Ben [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1100 DD Amsterdam, Netherlands
关键词
D O I
10.1136/jnnp.2006.110023
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To evaluate cognitive outcome in adult survivors of bacterial meningitis. Methods: Data from three prospective multicentre studies were pooled and reanalysed, involving 155 adults surviving bacterial meningitis ( 79 after pneumococcal and 76 after meningococcal meningitis) and 72 healthy controls. Results: Cognitive impairment was found in 32% of patients and this proportion was similar for survivors of pneumococcal and meningococcal meningitis. Survivors of pneumococcal meningitis performed worse on memory tasks (p < 0.001) and tended to be cognitively slower than survivors of meningococcal meningitis ( p = 0.08). We found a diffuse pattern of cognitive impairment in which cognitive speed played the most important role. Cognitive performance was not related to time since meningitis; however, there was a positive association between time since meningitis and self- reported physical impairment ( p< 0.01). The frequency of cognitive impairment and the numbers of abnormal test results for patients with and without adjunctive dexamethasone were similar. Conclusions: Adult survivors of bacterial meningitis are at risk of cognitive impairment, which consists mainly of cognitive slowness. The loss of cognitive speed is stable over time after bacterial meningitis; however, there is a significant improvement in subjective physical impairment in the years after bacterial meningitis. The use of dexamethasone was not associated with cognitive impairment.
引用
收藏
页码:1092 / 1096
页数:5
相关论文
共 23 条
[1]  
Alpherts WCJ, 1994, FEPSY
[2]   PNEUMOCOCCAL MENINGITIS - AN EVALUATION OF PROGNOSTIC FACTORS IN 164 CASES BASED ON MORTALITY AND ON A STUDY OF LASTING SEQUELAE [J].
BOHR, V ;
RASMUSSEN, N ;
HANSEN, B ;
GADE, A ;
KJERSEM, H ;
JOHNSEN, N ;
PAULSON, O .
JOURNAL OF INFECTION, 1985, 10 (02) :143-157
[3]   VALIDATING THE SF-36 HEALTH SURVEY QUESTIONNAIRE - NEW OUTCOME MEASURE FOR PRIMARY CARE [J].
BRAZIER, JE ;
HARPER, R ;
JONES, NMB ;
OCATHAIN, A ;
THOMAS, KJ ;
USHERWOOD, T ;
WESTLAKE, L .
BMJ-BRITISH MEDICAL JOURNAL, 1992, 305 (6846) :160-164
[4]   Dexamethasone in adults with bacterial meningitis. [J].
de Gans, J ;
van de Beek, D .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (20) :1549-1556
[5]   Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal meningitis in infant rats [J].
Leib, SL ;
Heimgartner, C ;
Bifrare, YD ;
Loeffler, JM ;
Täuber, MG .
PEDIATRIC RESEARCH, 2003, 54 (03) :353-357
[6]  
LEZAK MD, 2004, NEUROPSYCHOLOGICAL A
[7]  
LUTELIJIN F, 1983, GRONINGEN INTELLIGEN
[8]   Cognitive outcome after bacterial meningitis [J].
Merkelbach, S ;
Sittinger, H ;
Schweizer, I ;
Müller, M .
ACTA NEUROLOGICA SCANDINAVICA, 2000, 102 (02) :118-123
[9]  
NAESS A, 1994, ACTA NEUROL SCAND, V89, P139
[10]  
Reitan R.M., 1992, TRAIN MAKING TEST MA